|
Name |
Candidusin A
|
Molecular Formula | C20H16O6 | |
IUPAC Name* |
7-(4-hydroxyphenyl)-6,9-dimethoxydibenzofuran-2,3-diol
|
|
SMILES |
COC1=C2C3=CC(=C(C=C3OC2=C(C(=C1)C4=CC=C(C=C4)O)OC)O)O
|
|
InChI |
InChI=1S/C20H16O6/c1-24-17-8-12(10-3-5-11(21)6-4-10)19(25-2)20-18(17)13-7-14(22)15(23)9-16(13)26-20/h3-9,21-23H,1-2H3
|
|
InChIKey |
LMJVXQOOTLMXHB-UHFFFAOYSA-N
|
|
Synonyms |
Candidusin A; CHEBI:67539; MEGxm0_000166; CHEMBL1795468; ACon0_000993; ACon1_000819; NCGC00169328-01; Q27136008; 7-(4-hydroxyphenyl)-6,9-dimethoxydibenzofuran-2,3-diol; 7-(4-hydroxyphenyl)-6,9-dimethoxydibenzo[b,d]furan-2,3-diol
|
|
CAS | NA | |
PubChem CID | 24011606 | |
ChEMBL ID | CHEMBL1795468 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.3 | ALogp: | 4.2 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 92.3 | Aromatic Rings: | 4 |
Heavy Atoms: | 26 | QED Weighted: | 0.454 |
Caco-2 Permeability: | -5.029 | MDCK Permeability: | 0.00001760 |
Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.093 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.007 |
30% Bioavailability (F30%): | 0.168 |
Blood-Brain-Barrier Penetration (BBB): | 0.003 | Plasma Protein Binding (PPB): | 93.59% |
Volume Distribution (VD): | 0.568 | Fu: | 9.02% |
CYP1A2-inhibitor: | 0.956 | CYP1A2-substrate: | 0.914 |
CYP2C19-inhibitor: | 0.633 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.696 | CYP2C9-substrate: | 0.924 |
CYP2D6-inhibitor: | 0.343 | CYP2D6-substrate: | 0.901 |
CYP3A4-inhibitor: | 0.302 | CYP3A4-substrate: | 0.237 |
Clearance (CL): | 12.318 | Half-life (T1/2): | 0.855 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.1 |
Drug-inuced Liver Injury (DILI): | 0.968 | AMES Toxicity: | 0.724 |
Rat Oral Acute Toxicity: | 0.164 | Maximum Recommended Daily Dose: | 0.761 |
Skin Sensitization: | 0.897 | Carcinogencity: | 0.368 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.909 |
Respiratory Toxicity: | 0.327 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002757 | 0.810 | D06GCK | 0.449 | ||||
ENC002471 | 0.762 | D04AIT | 0.379 | ||||
ENC002853 | 0.756 | D0K8KX | 0.371 | ||||
ENC005880 | 0.708 | D07MGA | 0.340 | ||||
ENC005039 | 0.611 | D0Q9ON | 0.327 | ||||
ENC005391 | 0.611 | D0AZ8C | 0.315 | ||||
ENC002772 | 0.573 | D0W8WB | 0.315 | ||||
ENC005040 | 0.564 | D0G4KG | 0.299 | ||||
ENC000826 | 0.538 | D0J7RK | 0.298 | ||||
ENC001573 | 0.523 | D0U3YB | 0.291 |